ArticleCureus2026
Peripartum Cardiomyopathy in India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Peripartum cardiomyopathy (PPCM) is characterized by left ventricular systolic dysfunction occurring toward the end of pregnancy or in the months following delivery. In India, delayed recognition due to overlap with physiological pregnancy symptoms often leads to advanced disease at presentation. This study aimed to evaluate the clinical profile, echocardiographic findings, management, and maternal-neonatal outcomes of PPCM cases managed at a tertiary care center. Methodology This retrospective observational study was conducted over three years in the Department of Obstetrics and Gynaecology at a tertiary care center. A total of 11 women fulfilling the European Society of Cardiology diagnostic criteria for PPCM were included. Demographic data, risk factors, clinical presentation, laboratory parameters, echocardiographic findings, management details, and maternal and neonatal outcomes were analyzed using descriptive statistics. Results The mean maternal age was 27.4 ± 6.1 years. Most patients were unbooked referrals (90.9%), and 54.5% presented in the antepartum period. Breathlessness was the predominant symptom (90.9%), with 90.9% presenting in New York Heart Association class III-IV. Preeclampsia was the most common associated risk factor (54.5%). Mean left ventricular ejection fraction (LVEF) at diagnosis was 35.3% (range = 15-45%). Severe left ventricular dysfunction (<30%) was observed in half of the cases. Intensive care unit admission was required in the majority, with mechanical ventilation in 27.3% and cardiogenic shock in 33.3%. Maternal mortality was 9.1%. At six months, 80% of survivors demonstrated recovery of left ventricular function (LVEF >50%), while 20% had persistent dysfunction. Preterm birth occurred in 44.4% of deliveries. Neonatal mortality was 11.1%, and neonatal intensive care unit admission was required in 22.2%. Conclusions PPCM remains an under-recognized yet potentially life-threatening cause of heart failure in pregnancy. Most patients present with severe left ventricular dysfunction but demonstrate significant recovery with timely multidisciplinary management. Increased clinical awareness, early diagnosis, and structured follow-up are essential to improve maternal and neonatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.